Lipids Metabolism and Cardiometabolic Diseases
Conflicts of Interest
References
- Cheng, X.; Ma, T.; Ouyang, F.; Zhang, G.; Bai, Y. Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999-2018. Int. J. Environ. Res. Public Health 2022, 19, 4726. [Google Scholar] [CrossRef] [PubMed]
- Soppert, J.; Lehrke, M.; Marx, N.; Jankowski, J.; Noels, H. Lipoproteins and lipids in cardiovascular disease: From mechanistic insights to therapeutic targeting. Adv. Drug Deliv. Rev. 2020, 159, 4–33. [Google Scholar] [CrossRef] [PubMed]
- Bhargava, S.; de la Puente-Secades, S.; Schurgers, L.; Jankowski, J. Lipids and lipoproteins in cardiovascular diseases: A classification. Trends Endocrinol. Metab. 2022, 33, 409–423. [Google Scholar] [CrossRef] [PubMed]
- Gaggini, M.; Sabatino, L.; Vassalle, C. Conventional and innovative methods to assess oxidative stress biomarkers in the clinical cardiovascular setting. Biotechniques 2020, 68, 223–231. [Google Scholar] [CrossRef] [PubMed]
- Gaggini, M.; Pingitore, A.; Vassalle, C. Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities. Metabolites 2021, 11, 719. [Google Scholar] [CrossRef]
- Djekic, S.; Vekic, J.; Zeljkovic, A.; Kotur-Stevuljevic, J.; Kafedzic, S.; Zdravkovic, M.; Ilic, I.; Hinic, S.; Cerovic, M.; Stefanovic, M.; et al. HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction. Int. J. Mol. Sci. 2023, 24, 9384. [Google Scholar] [CrossRef]
- Torres-Paz, Y.E.; Gamboa, R.; Fuentevilla-Álvarez, G.; Soto, M.E.; González-Moyotl, N.; Martínez-Alvarado, R.; Torres-Tamayo, M.; Ramírez-Marroquín, E.S.; Vásquez-Jiménez, X.; Sainz-Escarrega, V.; et al. Overexpression of microRNA-21-5p and microRNA-221-5p in Monocytes Increases the Risk of Developing Coronary Artery Disease. Int. J. Mol. Sci. 2023, 24, 8641. [Google Scholar] [CrossRef]
- Liu, C.-H.; Jiang, W.; Zeng, Q.; Wu, D.; Li, H.; Zhou, L.; Bai, L.; Tang, H. CircRNA-PI4KB Induces Hepatic Lipid Deposition in Non-Alcoholic Fatty Liver Disease by Transporting miRNA-122 to Extra-Hepatocytes. Int. J. Mol. Sci. 2023, 24, 1297. [Google Scholar] [CrossRef] [PubMed]
- Castaño, C.; Meza-Ramos, A.; Batlle, M.; Guasch, E.; Novials, A.; Párrizas, M. Treatment with EV-miRNAs Alleviates Obesity-Associated Metabolic Dysfunction in Mice. Int. J. Mol. Sci. 2022, 23, 14920. [Google Scholar] [CrossRef]
- Rajlic, S.; Surmann, L.; Zimmermann, P.; Weisheit, C.K.; Bindila, L.; Treede, H.; Velten, M.; Daiber, A.; Duerr, G.D. Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice. Int. J. Mol. Sci. 2022, 23, 12690. [Google Scholar] [CrossRef] [PubMed]
- Nieddu, G.; Michelucci, E.; Formato, M.; Ciampelli, C.; Obino, G.; Signore, G.; Di Giorgi, N.; Rocchiccioli, S.; Lepedda, A.J. Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report. Int. J. Mol. Sci. 2022, 23, 12449. [Google Scholar] [CrossRef] [PubMed]
- Mocciaro, G.; D’Amore, S.; Jenkins, B.; Kay, R.; Murgia, A.; Herrera-Marcos, L.V.; Neun, S.; Sowton, A.P.; Hall, Z.; Palma-Duran, S.A.; et al. Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome. Int. J. Mol. Sci. 2022, 23, 6786. [Google Scholar] [CrossRef]
- Gaggini, M.; Gorini, F.; Vassalle, C. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia. Int. J. Mol. Sci. 2023, 24, 75. [Google Scholar] [CrossRef] [PubMed]
- Ravnskov, U.; de Lorgeril, M.; Kendrick, M.; Diamond, D.M. Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia. Int. J. Mol. Sci. 2022, 23, 9146. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gaggini, M.; Vassalle, C. Lipids Metabolism and Cardiometabolic Diseases. Int. J. Mol. Sci. 2023, 24, 17460. https://doi.org/10.3390/ijms242417460
Gaggini M, Vassalle C. Lipids Metabolism and Cardiometabolic Diseases. International Journal of Molecular Sciences. 2023; 24(24):17460. https://doi.org/10.3390/ijms242417460
Chicago/Turabian StyleGaggini, Melania, and Cristina Vassalle. 2023. "Lipids Metabolism and Cardiometabolic Diseases" International Journal of Molecular Sciences 24, no. 24: 17460. https://doi.org/10.3390/ijms242417460